CY1118473T1 - Η χρηση ενος αναστολεα της αγγειοπεπτιδασης για τη θεραπεια της πνευμονικης αρτηριακης υπερτασης - Google Patents
Η χρηση ενος αναστολεα της αγγειοπεπτιδασης για τη θεραπεια της πνευμονικης αρτηριακης υπερτασηςInfo
- Publication number
- CY1118473T1 CY1118473T1 CY20171100067T CY171100067T CY1118473T1 CY 1118473 T1 CY1118473 T1 CY 1118473T1 CY 20171100067 T CY20171100067 T CY 20171100067T CY 171100067 T CY171100067 T CY 171100067T CY 1118473 T1 CY1118473 T1 CY 1118473T1
- Authority
- CY
- Cyprus
- Prior art keywords
- inhibitor
- treatment
- vascular
- panel
- arterial hypertension
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/357—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having two or more oxygen atoms in the same ring, e.g. crown ethers, guanadrel
- A61K31/36—Compounds containing methylenedioxyphenyl groups, e.g. sesamin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Health & Medical Sciences (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Η παρούσα εφεύρεση αφορά στη χρήση ενός αναστολέα της αγγειοπεπτιδάσης για την παρασκευή ενός φαρμάκου για χρήση στη θεραπεία και/ή την πρόληψη της ΠΑΥ.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR0605250A FR2902009B1 (fr) | 2006-06-13 | 2006-06-13 | Utilisation d'un inhibiteur de vasopeptidase pour le traitement de l'hypertension arterielle pulmonaire |
PCT/FR2007/000970 WO2007144501A2 (fr) | 2006-06-13 | 2007-06-12 | Utilisation d'un inhibiteur de vasopeptidase pour le traitement de l'hypertension arterielle pulmonaire |
Publications (1)
Publication Number | Publication Date |
---|---|
CY1118473T1 true CY1118473T1 (el) | 2017-07-12 |
Family
ID=37603265
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CY20171100067T CY1118473T1 (el) | 2006-06-13 | 2017-01-18 | Η χρηση ενος αναστολεα της αγγειοπεπτιδασης για τη θεραπεια της πνευμονικης αρτηριακης υπερτασης |
Country Status (16)
Country | Link |
---|---|
US (1) | US20100234393A1 (el) |
EP (1) | EP2026796B1 (el) |
JP (1) | JP5421099B2 (el) |
CA (1) | CA2655019C (el) |
CY (1) | CY1118473T1 (el) |
DK (1) | DK2026796T3 (el) |
ES (1) | ES2611311T3 (el) |
FR (1) | FR2902009B1 (el) |
HR (1) | HRP20170123T1 (el) |
HU (1) | HUE030538T2 (el) |
LT (1) | LT2026796T (el) |
PL (1) | PL2026796T3 (el) |
PT (1) | PT2026796T (el) |
RS (1) | RS55663B1 (el) |
SI (1) | SI2026796T1 (el) |
WO (1) | WO2007144501A2 (el) |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2002083130A1 (en) * | 2001-04-16 | 2002-10-24 | Bristol-Myers Squibb Company | Enantiomers of n-[[2'-[[(4,5-dimethyl-3-isoxazolyl) amino]sulfonyl]-4-(2-oxazolyl)[1,1'-biphenyl]-2-yl]methyl]-n,3,3-trimethylbutanamide |
FR2837822B1 (fr) * | 2002-03-29 | 2004-06-04 | Bioprojet Soc Civ | Formes polymorphes du fasidotril, leurs procedes de preparation et compositions pharmaceutiques les contenant |
JP2005529927A (ja) * | 2002-05-23 | 2005-10-06 | ファイザー インコーポレイテッド | 新規な組み合わせ |
US20040077624A1 (en) * | 2002-05-23 | 2004-04-22 | Pfizer Inc. | Novel combination |
US20040220186A1 (en) * | 2003-04-30 | 2004-11-04 | Pfizer Inc. | PDE9 inhibitors for treating type 2 diabetes,metabolic syndrome, and cardiovascular disease |
AU2004266719A1 (en) * | 2003-08-22 | 2005-03-03 | Boehringer Ingelheim France S.A.S. | Methods of treating COPD and pulmonary hypertension |
EP1977741A3 (en) * | 2004-03-17 | 2009-10-14 | Novartis AG | Use of renin inhibitors in therapy |
EP1755589A4 (en) * | 2004-04-23 | 2007-11-07 | Celgene Corp | METHOD OF USING PDE4 MODULATORS AND COMPOSITIONS COMPRISING THEM FOR THE TREATMENT AND MANAGEMENT OF PULMONARY HYPERTENSION |
US20060205733A1 (en) * | 2004-08-26 | 2006-09-14 | Encysive Pharmaceuticals | Endothelin a receptor antagonists in combination with phosphodiesterase 5 inhibitors and uses thereof |
WO2006031931A2 (en) * | 2004-09-15 | 2006-03-23 | The President And Fellows Of Harvard College | Reducing er stress in the treatment of obesity and diabetes |
CA2608672A1 (en) * | 2005-05-24 | 2006-11-30 | Pharmacia & Upjohn Company Llc | Pyridine [3,4-b] pyrazinones as pde-5 inhibitors |
-
2006
- 2006-06-13 FR FR0605250A patent/FR2902009B1/fr active Active
-
2007
- 2007-06-12 LT LTEP07788875.8T patent/LT2026796T/lt unknown
- 2007-06-12 WO PCT/FR2007/000970 patent/WO2007144501A2/fr active Application Filing
- 2007-06-12 HU HUE07788875A patent/HUE030538T2/en unknown
- 2007-06-12 PL PL07788875T patent/PL2026796T3/pl unknown
- 2007-06-12 EP EP07788875.8A patent/EP2026796B1/fr active Active
- 2007-06-12 US US12/303,981 patent/US20100234393A1/en not_active Abandoned
- 2007-06-12 DK DK07788875.8T patent/DK2026796T3/en active
- 2007-06-12 RS RS20170104A patent/RS55663B1/sr unknown
- 2007-06-12 SI SI200731887A patent/SI2026796T1/sl unknown
- 2007-06-12 ES ES07788875.8T patent/ES2611311T3/es active Active
- 2007-06-12 JP JP2009514847A patent/JP5421099B2/ja not_active Expired - Fee Related
- 2007-06-12 PT PT77888758T patent/PT2026796T/pt unknown
- 2007-06-12 CA CA2655019A patent/CA2655019C/fr not_active Expired - Fee Related
-
2017
- 2017-01-18 CY CY20171100067T patent/CY1118473T1/el unknown
- 2017-01-25 HR HRP20170123TT patent/HRP20170123T1/hr unknown
Also Published As
Publication number | Publication date |
---|---|
LT2026796T (lt) | 2017-02-10 |
FR2902009A1 (fr) | 2007-12-14 |
EP2026796B1 (fr) | 2016-11-09 |
CA2655019C (fr) | 2014-11-25 |
JP5421099B2 (ja) | 2014-02-19 |
DK2026796T3 (en) | 2017-02-06 |
CA2655019A1 (fr) | 2007-12-21 |
HRP20170123T1 (hr) | 2017-03-24 |
SI2026796T1 (sl) | 2017-02-28 |
WO2007144501A3 (fr) | 2008-02-21 |
PT2026796T (pt) | 2017-01-17 |
EP2026796A2 (fr) | 2009-02-25 |
WO2007144501A2 (fr) | 2007-12-21 |
PL2026796T3 (pl) | 2017-03-31 |
JP2009539949A (ja) | 2009-11-19 |
HUE030538T2 (en) | 2017-05-29 |
FR2902009B1 (fr) | 2012-12-07 |
ES2611311T3 (es) | 2017-05-08 |
RS55663B1 (sr) | 2017-06-30 |
US20100234393A1 (en) | 2010-09-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CY1124144T1 (el) | Συνθεσεις και μεθοδοι για θεραπεια εγκεφαλικου επεισοδιου σε ενα υποκειμενο επι ταυτοχρονης θεραπειας στατινης | |
CY1111437T1 (el) | Τετραϋδροπυρρολοπυριμιδινοδιονες και η χρηση τους ως αναστολεων της ανθρωπινης ουδετεροφιλης ελαστασης | |
CY1117959T1 (el) | 24-norudca για την αγωγη αυτοανοσης ηπατιτιδας | |
CY2016015I2 (el) | Αζετιδινες ως αναστολεις μεκ για τη θεραπευτικη αγωγη πολλαπλασιαστικων ασθενειων | |
CY1108748T1 (el) | Χρηση αναστολεων της il-18 για την αντιμετωπιση και/η προληψη περιφερικων αγγειακων παθησεων | |
CY1112813T1 (el) | 4-(4-κυανο-2-θειοαρυλ)διϋδροπυριμιδινονες και η χρηση αυτων | |
ECSP088440A (es) | Imidazopirazinas como inhibidores de proteinquinasa | |
ATE479673T1 (de) | Hemmer der neubildung menschlicher immundefekt- viren | |
TR201907874T4 (tr) | Düşük sülfat fukanlar kullanarak fibröz yapışmaları ya da inflamatuar hastalıkları inhibe etmeye yönelik farmasötik kompozisyonlar ve yöntemler. | |
EA200900091A1 (ru) | Новые показания к применению прямых ингибиторов тромбина в лечении сердечно-сосудистых заболеваний | |
EA200701995A1 (ru) | Способы уменьшения кальцификации | |
CY1117184T1 (el) | ΤΕΛΕΣΤΕΣ β-ΑΡΡΕΣΤΙΝΗΣ ΚΑΙ ΣΥΝΘΕΣΕΙΣ ΚΑΙ ΜΕΘΟΔΟΙΧΡΗΣΗΣ ΑΥΤΩΝ | |
CY1115573T1 (el) | Τροποποιημενα ενζυμα λεκιθινοχοληστερολικης ακυλοτρανσφερασης | |
DK2034999T3 (da) | DHA-estere og anvendelse deraf i behandlingen og forebyggelsen af cardiovaskulære sygdomme | |
CY1114760T1 (el) | Θεραπευτικη αγωγη αθηροσκληρωσης | |
BRPI0906608A2 (pt) | Métodos e composições para o tratamento de hemorragia subaracnóide aneurismal coronária e arterial. | |
CY1116216T1 (el) | Μεθοδος θεραπειας ασθενειας αποθηκευσης γλυκογονου | |
CY1116938T1 (el) | Αναπληρωτικη θεραπεια της ασθενειας huntington και αλλων ασθενειων πολυγλουταμiνης | |
CY1110538T1 (el) | S-μιρταζαπινη για τη θεραπεια των εξαψεων | |
CY1115194T1 (el) | Χρηση της μακρας πεντραξινης ptx3 για την προληψη ή θεραπεια ιικων ασθενειων | |
DK3156057T3 (da) | Delmopinol-belagt dyretyggeartikel til anvendelse til forebyggelsen eller behandlingen af halitosis | |
NO20080781L (no) | GLEPP-inhibitorer i behandlingen av autoimmune og/eller inflammatoriske sykdommer | |
EA201001517A1 (ru) | Замещенные пиперидины в качестве терапевтических соединений | |
CY1118473T1 (el) | Η χρηση ενος αναστολεα της αγγειοπεπτιδασης για τη θεραπεια της πνευμονικης αρτηριακης υπερτασης | |
TR201901012T4 (tr) | Arteriosklerozun tedavisinde nor-safra asitlerinin kullanımı. |